CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

iSpecimen (ISPC) jumps 61% after $21m private placement

By Kevin Donovan

21:10, 29 November 2021

iSpecimen marketplace platform
iSpecimen up 61% on private placement announcement - Photo: iSpecimen

iSpecimen stock jumped over 60% Monday on heavy trading volume after the biopharma microcap announced a $21m private-placement transaction that would also prevent it from issuing new shares for the next 20 months. As of late Monday, $21m equalled £15.8m, according to currency exchange tracker

After trading 61.9% higher after the opening bell to a new 52-week high of $28.98, iSpecimen stock closed Monday at $20.42, up 14.1% from Friday’s $17.90 early market close share price on over 55 million trading volume, versus 4.46 million daily average trading volume, according to data maintained by Nasdaq. iSpecimen shares trade over the Nasdaq exchange under the ticker ISPC.

Private placement details

iSpecimen announced before the market open on Monday it completed a private placement transaction with three investors for a mix of stock and options, raising $21m. Per the agreement, the three investors will purchase roughly 1.75 million shares and 1.32 million warrants to purchase shares at a $13 per share strike price by mid-2027. The combined cost per share plus three-quarters of a warrant is $12.

Closing is scheduled for 1 December. Additionally, iSpecimen announced it would not issue further shares, or announce the planned issuance of shares, of its Class A common stock for at least 18 months after the shares and warrants are freed to trade following a 60-day lock-up period.

ThinkEquity, which acted as sole underwriter on iSpecimin’s May initial offering of shares to the public, acted as sole placement agent for the transaction. On 27 May, iSpecimen sold 2.25 million shares in its IPO at $8 per share, raising $18m.


240.50 Price
-0.630% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.13


15.93 Price
-2.600% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.15


125.05 Price
-0.570% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.25


0.71 Price
+0.640% 1D Chg, %
Long position overnight fee -0.0253%
Short position overnight fee 0.0033%
Overnight fee time 22:00 (UTC)
Spread 0.0030

Wild week

This continues a strong push for iSpecimen, which saw shares rise over 80% last Tuesday after announcing it was contracted to supply human specimens to both public and private Covid-19 clinical research trials, including the US government. iSpecimen had been working with the US Centers for Disease Control and Prevention (CDC) since last year, providing roughly 700 serum samples to monitor antibody development.

iSpecimen stock closed last Monday 22 November at $8.89 per share, before Tuesday’s sample-supply contract announcement sent the stock to $18.50 per share. Additionally, iSpecimen reported strong third-quarter 2021 earnings earlier this month, with revenue through the first nine months of 2021 surpassing its full-year 2020 revenue.

Lexington, Massachusetts-based iSpecimen procures human biospecimens for clinical research over its web-based platform, iSpecimen Marketplace. iSpecimen offers researchers banked specimens, archived samples and remnants of clinical lab samples.

Read more: The funds that have consistently delivered

Rate this article

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading